papillary thyroid cancer
carcinoma papillare latin

But among older people, the cure rates for papillary thyroid cancer are often lower.

In early 2002, Ebert was diagnosed with papillary thyroid cancer.

Papillary thyroid cancer: The most common type of thyroid cancer.

Thyroglobulin can be used as a tumor marker for well-differentiated papillary thyroid cancer.

Papillary thyroid cancer has been reported to affect 1% to 2% of patients with FAP.

Mutations associated with papillary thyroid cancer are mainly two forms of chromosomal translocation and one form of point mutation.

Papillary microcarcinoma is a subset of papillary thyroid cancer defined as measuring less than or equal to 1 cm.

Follicular and papillary thyroid cancers are sometimes treated with radioactive iodine (RAI) therapy.

GEO profiles also show that expression of "C1orf123" does not change in papillary thyroid cancer or chlamydia pneumonia infection.

In November 2010 he underwent surgery to remove his thyroid gland after being diagnosed with papillary thyroid cancer, from which he is expected to recover.

Papillary thyroid cancer (PTC).

A second type, follicular, accounts for about 15 percent of thyroid cancers, and its prognosis is not as favorable as the one for papillary thyroid cancer.

The prognosis of MTC is poorer than that of follicular and papillary thyroid cancer when it has metastasized (spread) beyond the thyroid gland.

There is also a connection between the V600E mutation of the BRAF oncogene and papillary thyroid cancer that cannot concentrate iodine into its follicular cells.

Papillary thyroid cancer or papillary thyroid carcinoma is the most common type of thyroid cancer, representing 75% to 85% of all thyroid cancer cases.

The gene NTRK1 (encoding the TrkA receptor), located on chromosome 1q, is similarly translocated in approximately 5% to 10% of papillary thyroid cancers.

Although level 1 evidence is lacking, a consensus opinion recommends annual thyroid examinations beginning in the late teenage years to screen for papillary thyroid cancer in patients with FAP.

Flannery TK, Kirkland JL, Copeland KC, et al.: Papillary thyroid cancer: a pediatric perspective.

Thyroid disease (both benign conditions like thyrotoxicosis and malignant conditions like papillary thyroid cancer) can be treated with radioactive iodine (iodine-131) which is then concentrated into the thyroid.

The MAICS system of estimating the prognosis of papillary thyroid cancer was developed by the Mayo Clinic, and was based on careful evaluation of a large group of patients.

Lennard CM, Patel A, Wilson J, et al.: Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage III papillary thyroid cancer and stage III follicular thyroid cancer.

Chromosomal translocations involving the RET proto-oncogene (encoding a tyrosine kinase receptor that plays essential roles in the development of neuroendocrine cells) located on chromosome 10q11 occur in approximately a fifth of papillary thyroid cancers.

Activating mutations in the BRAF gene, primarily V600E (meaning that the amino acid valine in position 600 is replaced by glutamic acid), are associated with lower survival rates in patients with papillary thyroid cancer.

Further studies are needed to show whether other genetic factors such as the RET/PTC chimeric gene are independently responsible for or cooperative with APC mutations in causing papillary thyroid cancers in FAP patients.